BACKGROUND: Long-term exposure to high levels of arsenic is associated with increased risk for cardiovascular disease, whereas risk from long-term exposure to low to moderate arsenic levels (< 100μg/L in drinking water) is unclear. OBJECTIVE: To evaluate the association between long-term exposure to low to moderate arsenic levels and incident cardiovascular disease. DESIGN: Prospective cohort study. SETTING: The Strong Heart Study baseline visit between 1989 and 1991, with follow-up through 2008. PATIENTS: 3575 American Indian men and women aged 45 to 74 years living in Arizona, Oklahoma, and North and South Dakota. MEASUREMENTS: The sum of inorganic and methylated arsenic species in urine at baseline was used as a biomarker of long-term arsenic exposure. Outcomes were incident fatal and nonfatal cardiovascular disease. RESULTS: A total of 1184 participants developed fatal and nonfatal cardiovascular disease. When the highest and lowest quartiles of arsenic concentrations (> 15.7 vs. < 5.8 μg/g creatinine) were compared,the hazard ratios for cardiovascular disease, coronary heart disease, and stroke mortality after adjustment for sociodemographic factors, smoking, body mass index, and lipid levels were 1.65 (95%CI, 1.20 to 2.27; P for trend < 0.001), 1.71 (CI, 1.19 to 2.44; P for trend < 0.001), and 3.03 (CI, 1.08 to 8.50; P for trend = 0.061),respectively. The corresponding hazard ratios for incident cardiovascular disease, coronary heart disease, and stroke were 1.32 (CI,1.09 to 1.59; P for trend = 0.002), 1.30 (CI, 1.04 to 1.62; P for trend = 0.006), and 1.47 (CI, 0.97 to 2.21; P for trend = 0.032).These associations varied by study region and were attenuated after further adjustment for diabetes, hypertension, and kidney disease measures. LIMITATION: Direct measurement of individual arsenic levels in drinking water was unavailable. CONCLUSION: Long-term exposure to low to moderate arsenic levels was associated with cardiovascular disease incidence and mortality.
BACKGROUND: Long-term exposure to high levels of arsenic is associated with increased risk for cardiovascular disease, whereas risk from long-term exposure to low to moderate arsenic levels (< 100μg/L in drinking water) is unclear. OBJECTIVE: To evaluate the association between long-term exposure to low to moderate arsenic levels and incident cardiovascular disease. DESIGN: Prospective cohort study. SETTING: The Strong Heart Study baseline visit between 1989 and 1991, with follow-up through 2008. PATIENTS: 3575 American Indian men and women aged 45 to 74 years living in Arizona, Oklahoma, and North and South Dakota. MEASUREMENTS: The sum of inorganic and methylated arsenic species in urine at baseline was used as a biomarker of long-term arsenic exposure. Outcomes were incident fatal and nonfatal cardiovascular disease. RESULTS: A total of 1184 participants developed fatal and nonfatal cardiovascular disease. When the highest and lowest quartiles of arsenic concentrations (> 15.7 vs. < 5.8 μg/g creatinine) were compared,the hazard ratios for cardiovascular disease, coronary heart disease, and stroke mortality after adjustment for sociodemographic factors, smoking, body mass index, and lipid levels were 1.65 (95%CI, 1.20 to 2.27; P for trend < 0.001), 1.71 (CI, 1.19 to 2.44; P for trend < 0.001), and 3.03 (CI, 1.08 to 8.50; P for trend = 0.061),respectively. The corresponding hazard ratios for incident cardiovascular disease, coronary heart disease, and stroke were 1.32 (CI,1.09 to 1.59; P for trend = 0.002), 1.30 (CI, 1.04 to 1.62; P for trend = 0.006), and 1.47 (CI, 0.97 to 2.21; P for trend = 0.032).These associations varied by study region and were attenuated after further adjustment for diabetes, hypertension, and kidney disease measures. LIMITATION: Direct measurement of individual arsenic levels in drinking water was unavailable. CONCLUSION: Long-term exposure to low to moderate arsenic levels was associated with cardiovascular disease incidence and mortality.
Authors: Barbro Nermell; Anna-Lena Lindberg; Mahfuzar Rahman; Marika Berglund; Lars Ake Persson; Shams El Arifeen; Marie Vahter Journal: Environ Res Date: 2007-09-27 Impact factor: 6.498
Authors: Maria Tellez-Plaza; Matthew O Gribble; V Saroja Voruganti; Kevin A Francesconi; Walter Goessler; Jason G Umans; Ellen K Silbergeld; Eliseo Guallar; Nora Franceschini; Kari E North; Wen H Kao; Jean W MacCluer; Shelley A Cole; Ana Navas-Acien Journal: Environ Health Perspect Date: 2013-01-15 Impact factor: 9.031
Authors: Katherine A Moon; Yiyi Zhang; Eliseo Guallar; Kevin A Francesconi; Walter Goessler; Jason G Umans; Lyle G Best; Barbara V Howard; Richard B Devereux; Peter M Okin; Ana Navas-Acien Journal: Environ Pollut Date: 2018-05-26 Impact factor: 8.071
Authors: Clint R Carroll; Carolyn Noonan; Eva M Garroutte; Ana Navas-Acien; Steven P Verney; Dedra Buchwald Journal: Environ Res Date: 2017-05-12 Impact factor: 6.498
Authors: Cari L Tsinovoi; Pengcheng Xun; Leslie A McClure; Vivian M O Carioni; John D Brockman; Jianwen Cai; Eliseo Guallar; Mary Cushman; Frederick W Unverzagt; Virginia J Howard; Ka He Journal: Stroke Date: 2017-12-06 Impact factor: 7.914
Authors: Miranda J Spratlen; Maria Grau-Perez; Lyle G Best; Joseph Yracheta; Mariana Lazo; Dhananjay Vaidya; Poojitha Balakrishnan; Mary V Gamble; Kevin A Francesconi; Walter Goessler; Shelley A Cole; Jason G Umans; Barbara V Howard; Ana Navas-Acien Journal: Am J Epidemiol Date: 2018-08-01 Impact factor: 4.897
Authors: Khadijah Breathett; Mario Sims; Marie Gross; Elizabeth A Jackson; Emily J Jones; Ana Navas-Acien; Herman Taylor; Kevin L Thomas; Barbara V Howard Journal: Circulation Date: 2020-05-28 Impact factor: 29.690
Authors: Francesco Stea; Francesco Faita; Andrea Borghini; Francesca Faita; Fabrizio Bianchi; Elisa Bustaffa; Fabrizio Minichilli; Maria Grazia Andreassi; Rosa Sicari Journal: Environ Sci Pollut Res Int Date: 2016-07-23 Impact factor: 4.223